Northwestern Mutual Wealth Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1K Hold
1,200
﹤0.01% 2894
2026
Q1
$15.8K Hold
1,200
﹤0.01% 2891
2025
Q4
$18.5K Sell
1,200
-50
-4% -$669 ﹤0.01% 2773
2025
Q3
$12.9K Buy
1,250
+50
+4% +$471 ﹤0.01% 2820
2025
Q2
$13.4K Hold
1,200
﹤0.01% 2705
2025
Q1
$14.7K Buy
+1,200
New +$15K ﹤0.01% 2614

Other funds holding NPCE

Northwestern Mutual Wealth Management's NPCE Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Neuropace (NPCE) position steady in Q2 2026 at 1,200 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

Northwestern Mutual Wealth Management first reported a position in NPCE in Q1 2025 and has held it in 6 quarters since. 74 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Northwestern Mutual Wealth Management held 1,200 shares of Neuropace worth $19.1K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Neuropace share count unchanged in Q2 2026.
  • Neuropace made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2894 holding.
  • Northwestern Mutual Wealth Management first reported a position in Neuropace in Q1 2025 and has held it in 6 quarters since.
  • 74 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.